Skip to content

MALIGNANCY RISK STRATIFICATION OF THYROID NODULES: COMPARISON BETWEEN THE AMERICAN COLLEGE OF RADIOLOGY THYROID IMAGING REPORTING AND DATA SYSTEM (ACR TI-RADS) AND THE AMERICAN THYROID ASSOCIATION (ATA) MANAGEMENT GUIDELINES

MALIGNANCY RISK STRATIFICATION OF THYROID NODULES: COMPARISON BETWEEN THE AMERICAN COLLEGE OF RADIOLOGY THYROID IMAGING REPORTING AND DATA SYSTEM (ACR TI-RADS) AND THE AMERICAN THYROID ASSOCIATION (ATA) MANAGEMENT GUIDELINES IN NORTHERN THAILAND.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20230208002
Enrollment
40
Registered
2023-02-08
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACR TI-RADS recommend for follow up if size of thyroid nodule is less than 1.5 cm. ACR TI-RADS ATA-guidelines

Interventions

The nodules which give the ACR TI-RADS to evaluated and stratified malignancy risk. ,The nodules which give the ATA Guidelines to evaluated and stratified malignancy risk.
Diagnostic,Diagnostic
ACR TI-RADS group ,ATA guideline group

Sponsors

LAMPANG HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1. Thyroid nodule with suspicious findings of malignancy. 2. Thyroid function test (FT3, FT4 or TSH) 3. Proven tissue path (FNA or thyroidectomy)

Exclusion criteria

Exclusion criteria: 1. Thyroid nodules size less than 10 mm. 2. Missing some FT3, FT4 or TSH 3. The pre-biopsy imaging were performed from another medical center.

Design outcomes

Primary

MeasureTime frame
Malignancy Risk at 12 months after end of the intervention ACR TI-RADS

Secondary

MeasureTime frame
Malignancy Risk. at 12 months after end of the intervention ATA guidelines

Countries

Thailand

Contacts

Public ContactSarawadee Chatchavan

Lampang Hospital

sarawadee135@hotmail.com66817645890

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026